Moderna, Inc. - Common Stock (MRNA)

CUSIP: 60770K107

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
388,311,585
Total 13F shares
84,483,070
Share change
+9,794,410
Total reported value
$1,235,871,867
Put/Call ratio
37%
Price per share
$14.64
Number of holders
128
Value change
+$117,389,510
Number of buys
90
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 60770K107?
CUSIP 60770K107 identifies MRNA - Moderna, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MRNA - Moderna, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VIKING GLOBAL INVESTORS LP
13F
Company
4.3%
16,667,866
$339,191,000 31 Mar 2019
13F
FMR LLC
13F
Company
3.9%
15,214,205
$296,225,000 31 Mar 2019
13F
Artal Group S.A.
13F
Company
1.3%
5,006,298
$101,878,000 31 Mar 2019
13F
BB BIOTECH AG
13F
Company
1.2%
4,785,681
$97,389,000 31 Mar 2019
13F
FIDUCIARY TRUST CO
13F
Company
1.1%
4,311,926
$87,748,000 31 Mar 2019
13F
MORGAN STANLEY
13F
Company
0.88%
3,413,245
$69,459,000 31 Mar 2019
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.79%
3,052,676
$62,122,000 31 Mar 2019
13F
BAILLIE GIFFORD & CO
13F
Company
0.66%
2,575,201
$52,405,000 31 Mar 2019
13F
WADDELL & REED FINANCIAL INC
13F
Company
0.45%
1,728,342
$35,172,000 31 Mar 2019
13F
Theleme Partners LLP
13F
Company
0.42%
1,632,513
$33,222,000 31 Mar 2019
13F
FIL Ltd
13F
Company
0.42%
1,616,898
$32,904,000 31 Mar 2019
13F
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
0.41%
1,600,000
$32,560,000 31 Mar 2019
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
0.39%
1,513,929
$30,808,000 31 Mar 2019
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.38%
1,473,876
$29,993,000 31 Mar 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.37%
1,436,240
$29,227,000 31 Mar 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.3%
1,170,445
$23,819,000 31 Mar 2019
13F
CREDIT SUISSE AG/
13F
Company
0.27%
1,052,209
$21,413,000 31 Mar 2019
13F
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
13F
Company
0.25%
978,434
$19,911,000 31 Mar 2019
13F
HIGHLINE CAPITAL MANAGEMENT, L.P.
13F
Company
0.24%
930,230
$18,930,000 31 Mar 2019
13F
VANGUARD GROUP INC
13F
Company
0.22%
868,516
$17,674,000 31 Mar 2019
13F
NORGES BANK
13F
Company
0.21%
825,000
$16,789,000 31 Mar 2019
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.21%
819,775
$15,986,000 31 Mar 2019
13F
AMUNDI ASSET MANAGEMENT US, INC.
13F
Company
0.19%
739,148
$15,042,000 31 Mar 2019
13F
Neuberger Berman Group LLC
13F
Company
0.18%
704,955
$14,346,000 31 Mar 2019
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.17%
645,357
$13,133,000 31 Mar 2019
13F
BlackRock Finance, Inc.
13F
Company
0.15%
568,431
$11,567,000 31 Mar 2019
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.13%
490,855
$9,989,000 31 Mar 2019
13F
Mitsubishi UFJ Trust & Banking Corp
13F
Company
0.11%
433,010
$8,812,000 31 Mar 2019
13F
Hitchwood Capital Management LP
13F
Company
0.09%
350,000
$7,123,000 31 Mar 2019
13F
STATE STREET CORP
13F
Company
0.08%
301,980
$6,145,000 31 Mar 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.07%
280,136
$5,700,000 31 Mar 2019
13F
Laurion Capital Management LP
13F
Company
0.06%
250,000
$5,088,000 31 Mar 2019
13F
CITADEL ADVISORS LLC
13F
Company
0.04%
159,108
$3,238,000 31 Mar 2019
13F
EDMOND DE ROTHSCHILD HOLDING S.A.
13F
Company
0.04%
155,000
$3,154,000 31 Mar 2019
13F
HELLMAN JORDAN MANAGEMENT CO INC /MA/
13F
Company
0.04%
140,204
$2,853,000 31 Mar 2019
13F
Athos Capital Ltd
13F
Company
0.03%
114,597
$2,332,000 31 Mar 2019
13F
ROYAL BANK OF CANADA
13F
Company
0.03%
112,589
$2,292,000 31 Mar 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
109,169
$2,221,000 31 Mar 2019
13F
Man Group plc
13F
Company
0.02%
96,104
$1,955,000 31 Mar 2019
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.02%
94,937
$1,932,000 31 Mar 2019
13F
HSG Holding Ltd
13F
Company
0.02%
91,195
$1,856,000 31 Mar 2019
13F
Sculptor Capital LP
13F
Company
0.02%
84,100
$1,711,000 31 Mar 2019
13F
Vident Investment Advisory, LLC
13F
Company
0.02%
82,315
$1,675,000 31 Mar 2019
13F
BARCLAYS PLC
13F
Company
0.02%
72,831
$1,482,000 31 Mar 2019
13F
Flagship Pioneering, LLC
13F
Company
15%
58,807,379
$1,196,730 31 Mar 2019
13F
Legal & General Group Plc
13F
Company
0.01%
57,589
$1,170,000 31 Mar 2019
13F
Moloney Securities Asset Management, LLC
13F
Company
0.01%
51,638
$1,051,000 31 Mar 2019
13F
NORTHERN TRUST CORP
13F
Company
0.01%
49,463
$1,007,000 31 Mar 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
42,467
$864,000 31 Mar 2019
13F
CWM, LLC
13F
Company
0%
3,423
$804,000 31 Mar 2019
13F

Institutional Holders of Moderna, Inc. - Common Stock (MRNA) as of Q2 2019

As of 30 Jun 2019, Moderna, Inc. - Common Stock (MRNA) was held by 128 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 84,483,070 shares. The largest 10 holders included FMR LLC, Viking Global Investors LP, Ropes Wealth Advisors LLC, MORGAN STANLEY, Bellevue Group AG, Artal Group S.A., FIDUCIARY TRUST CO, BANQUE PICTET & CIE SA, Theleme Partners LLP, and BAILLIE GIFFORD & CO. This page lists 128 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
101
Q2 2019 holders
128
Holder diff
27
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.